ArticleRheumatology and therapy2023

Influenza Adverse Events in Patients with Rheumatoid Arthritis, Ulcerative Colitis, or Psoriatic Arthritis in the Tofacitinib Clinical Development Programs.

Kevin L Winthrop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.